Biohaven Ltd (BHVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 132,149 | 316,231 | 261,061 | 428,239 | N/A |
| Marketable Securities | 223,185 | 229,983 | N/A | N/A | N/A |
| Receivables | 120,111 | 79,522 | 44,796 | 4,337 | N/A |
| Inventories | 39,563 | 20,131 | 8,970 | 4,582 | N/A |
| Other current assets | 11,716 | 0 | 0 | 0 | 0 |
| TOTAL | $603,406 | $708,285 | $362,562 | $474,446 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 9,340 | 8,802 | 8,979 | 8,933 | N/A |
| Investments And Advances | 1,176 | 1,866 | 2,473 | 3,958 | 0 |
| Intangibles | 39,087 | 39,811 | 40,535 | 41,259 | 0 |
| Other Non-Current Assets | 33,966 | 23,251 | 9,706 | 4,073 | 0 |
| TOTAL | $83,569 | $73,730 | $61,693 | $58,223 | $N/A |
| Total Assets | $686,975 | $782,015 | $424,255 | $532,669 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 48,476 | 43,976 | 17,044 | 29,703 | 0 |
| Accrued Expenses | 166,630 | 126,267 | 118,123 | 76,770 | N/A |
| Other current liabilities | 62,500 | 46,875 | 31,250 | 15,625 | N/A |
| TOTAL | $277,606 | $217,118 | $166,417 | $122,098 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 267,458 | 264,135 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 534,100 | 516,019 | 293,304 | 288,613 | 0 |
| TOTAL | $801,558 | $778,715 | $293,304 | $288,613 | $N/A |
| Total Liabilities | $1,079,164 | $995,833 | $459,721 | $410,711 | $351,688 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,915 | 59,939 | 59,687 | 58,532 | 58,283 |
| Common Shares | 1,249,547 | 1,205,384 | 1,199,005 | 1,175,139 | N/A |
| Retained earnings | -1,739,169 | -1,521,433 | -1,326,244 | -1,145,310 | N/A |
| Other shareholders' equity | -1,505 | -1,188 | 0 | 0 | 0 |
| TOTAL | $-392,189 | $-213,818 | $-35,466 | $121,958 | $N/A |
| Total Liabilities And Equity | $686,975 | $782,015 | $424,255 | $532,669 | $351,688 |